Breast Cancer Expert: “Awareness and Early Detection Save Lives”

One in eight women will be diagnosed with breast cancer in her lifetime.    For those with BRCA1 and BRCA2 gene mutations, the chances are even higher. The National Breast Cancer Foundation estimates that 55 to 65% of women with the BRCA1 mutation, and 45%…

$1.8 Million NIH Grant Supports Head and Neck Cancer Research

Sylvester Comprehensive Cancer Center researchers Lluis Morey, Ph.D., and Ramiro Verdun, Ph.D., have received a $1.8 million NIH R01 grant to study the epigenetic mechanisms that drive head and neck cancers.

Cancer Expert Shares Troubling Research on World Trade Center Exposure

Police officers and construction workers who responded on September 11, 2001, to the World Trade Center disaster in New York City and worked in its aftermath had at least twice the risk of developing the precursor for multiple myeloma compared…

Cleveland Clinic Receives $7.9 Million Grant from National Institutes of Health to Form Radiation Oncology-Biology Integration Network (ROBIN)

Cleveland Clinic received a $7.9 million five-year grant from the National Cancer Institute at the National Institutes of Health to form one of three national centers as part of the newly established Radiation Oncology-Biology Integration Network (ROBIN).

Anti-sedative could alleviate cancer therapy side effects, study suggests

Researchers in China have discovered that inhibiting a protein called the GABAA receptor can protect intestinal stem cells from the toxic effects of chemotherapy and radiotherapy. The study, published September 20 in the Journal of Experimental Medicine (JEM), suggests that the FDA-approved anti-sedative flumazenil, which targets GABAA receptors, could alleviate some of the common gastrointestinal side effects, such as diarrhea and vomiting, induced by many cancer treatments.

Van Andel Institute awarded $7.9 million to continue role as Cancer Moonshot(SM) Biobank Biorepository

Van Andel Institute’s Biorepository has been awarded a $7.9 million, five-year contract from the National Cancer Institute (NCI), part of the National Institutes of Health, to continue serving as the biorepository for the Cancer MoonshotSM Biobank study. The Institute has served as the Cancer MoonshotSM Biobank Biorepository since 2020, when it was awarded a two-year subcontract to develop the framework and protocols for this part of the initiative.

New Study Shows Sugar-Sweetened Drinks Increase Risk of Cancer Mortality

In a large study led by researchers at the American Cancer Society, men and women who drank two or more servings of sugar-sweetened beverages (SSB) per day, compared to people who never drank, had a five percent increased risk of death from an obesity-related cancer, including gastrointestinal, postmenopausal breast, endometrial and kidney cancer.

New Study Shows Patients Paying More Out-of-Pocket Costs for Cancer Care

A new, large study led by researchers at the American Cancer Society and The University of Texas MD Anderson Cancer Center shows rising costs of cancer treatments led to increases in total costs of care, and when compounded with greater cost sharing, increased out-of-pocket costs for privately insured, patients under 65 years old.

Estudio de Mayo Clinic demuestra que la inteligencia artificial puede ayudar a predecir mejor la recurrencia del cáncer colorrectal

En un estudio multinacional dirigido por un equipo de investigación de Mayo Clinic que empleó la inteligencia artificial, los investigadores desarrollaron un algoritmo para predecir mejor la recurrencia del cáncer colorrectal. Los resultados del estudio se publicaron en Gastroenterología.

RUSH, Franciscan to Partner on Clinical Services for Cancer, Neurosciences

Chicago-based Rush University System for Health and Franciscan Alliance, Inc., are partnering to jointly develop and provide clinical services to improve the availability of health care to patients in Northwest Indiana, giving patients streamlined access to subspecialty care in their own communities.

Cellular ‘waste product’ rejuvenates cancer-fighting immune cells

A new study by UT Southwestern’s Simmons Cancer Center scientists suggests that lactate, a metabolic byproduct produced by cells during strenuous exercise, can rejuvenate immune cells that fight cancer. The finding, published in Nature Communications, could eventually be used to develop new strategies to augment the anti-tumor effect of cancer immunotherapies, the study authors said.

Especialista da Mayo Clinic Healthcare explica quando os problemas para engolir são mais que um acidente

Muitas pessoas já experimentaram o desconforto de ter alimentos ou bebidas descendo acidentalmente pelo lugar errado ao engolir. Entretanto, problemas para engolir muitas vezes se tornam crônicos e podem ser um sinal de alguma doença que precisa ser tratada.

Experto de Mayo Clinic Healthcare explica cuándo los problemas de deglución se consideran más que un accidente

Muchas personas experimentan la incomodad de que un alimento o bebida se vaya accidentalmente por el lugar equivocado durante la deglución. Sin embargo, los problemas de deglución a veces se vuelven crónicos y pueden ser la señal de una enfermedad que debería tratarse.

WORLD-RENOWNED CANCER EXPERT SHARES TROUBLING RESEARCH ON WORLD TRADE CENTER EXPOSURE

Miami, Fla. – September 11, 2001, changed America, and today we are learning more about the long-term health impacts of unprecedented environmental exposure to carcinogens at the World Trade Center disaster site.  New research suggests that emergency response and recovery…

Mayo Clinic Healthcare expert explains when swallowing issues are more than an accident

Many people have experienced the discomfort of food or a beverage accidentally going to the wrong place when swallowing. But swallowing issues sometimes become chronic and may be a sign of a health condition that should be treated.

Henry Ford Health + MSU Health Sciences Funds Five Cancer Research Grants to Advance Cancer Medicine, Combat Health Disparities

Henry Ford Health + Michigan State University Health Sciences today announced its funding of five cancer research grants of up to $100,000 each. These five grants follow an initial wave of funding from the partnership, in which 18 pilot grants of up to $25,000 each were funded in May 2022.

Brentuximab vedotina puede mejorar la supervivencia general en pacientes con linfoma de Hodgkin

Un estudio dirigido por los científicos del Centro Oncológico Integral de Mayo Clinic descubrió que la adición de brentuximab vedotina a la quimioterapia estándar mejora la supervivencia general de los pacientes con linfoma de Hodgkin, comparado con la administración de solo la quimioterapia estándar.

Medicamento brentuximab vedotina pode melhorar a sobrevida geral de pacientes com linfoma de Hodgkin

Um estudo conduzido por pesquisadores do Centro de Câncer da Mayo Clinic descobriu que adicionar o brentuximab vedotina ao tratamento quimioterápico padrão aumenta a taxa geral de sobrevida de pacientes com linfoma de Hodgkin, em comparação com o padrão de tratamento atual que usa somente a quimioterapia.

Modified bladder cancer treatment shows promise in animal studies

A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects. Results in mouse models and human cells show promising results and pave the way for human clinical trials. The research, conducted in close collaboration with UT Health San Antonio, was published online in June in the journal Cancer Immunology, Immunotherapy.

Intricate Interplay

Kimberly Leslie, MD, was awarded a four-year, $1.8 million grant from the Department of Defense (DOD) to further study high-risk uterine cancer. Her research has led her to study the differences between natural progesterone and synthetic progestins – hormones often used for birth control – and the influence of progesterone on a tumor suppressor protein called p53. The hormones, drugs and proteins, she’s learned, influence each other and the body’s cells in complex ways.

New UCI-led research reveals the circadian clock influences cell growth, metabolism and tumor progression

In a new University of California, Irvine-led study, researchers define how the circadian clock influences cell growth, metabolism and tumor progression. Their research also reveals how disruption of the circadian clock impacts genome stability and mutations that can further drive critical tumor promoting pathways in the intestine.

Prompt Recognition and Treatment Found Effective for Lung Disease in Patients Who Received New Drug for Advanced Cancer

Lung disease caused by a new drug for cancers—including metastatic or advanced breast cancer—can be effectively treated using approaches that focus on early detection and prompt management, according to a study published in ESMO Open on August 11, 2022.

Traditional Chinese medicine reduces side effect of cancer treatment

For tens of thousands of Australians who receive radiotherapy as part of their cancer treatment, mucositis is a serious side effect that may cause inflammation, ulcers, diarrhoea, nausea and vomiting, abdominal pain and bloating. Currently there is no effective treatment for mucositis, but researchers from the University of Adelaide have found that a type of traditional Chinese medicine reduces the severity of radiation-induced gastrointestinal mucositis (GIM) in rats.

New Study Shows Two Million Life-Years Lost and $21 Billion in Lost Earnings Annually Due to Smoking Associated Cancer Deaths

A new study led by researchers at the American Cancer Society reports nearly 123,000 cancer deaths, or close to 30 percent of all cancer deaths, were from cigarette smoking in the United States in 2019, leading to more than two million Person-Years of Lost Life (PYLL) and nearly $21 billion in annual lost earnings. These losses were disproportionately higher in states with weaker tobacco control policies in the South and Midwest. The results were published today in the International Journal of Cancer.